Metabotropic Glutamate Receptor 2/3 Activation Improves Motor Performance and Reduces Pathology in Heterozygous zQ175 Huntington Disease MiceSi Han Li, Stephen S. G. Ferguson|Journal of Pharmacology and Experimental Therapeutics|2021Cited by 18